Counseling Points - Psychiatric Nurse 11/08 - (Page 2)

Faculty: Nancy Ferguson-Noyes, APRN, BC Private Child and Adolescent Psychiatry Practice Scarborough, Maine Ann M. Wilkinson, MSN, APRN, PMHCNS-BC Psychiatric Clinical Nurse Specialist, Private Practice Redwood City, California Faculty Disclosure Statements Nancy Ferguson-Noyes and Ann M. Wilkinson have no conflicts of interest to report. Publishing Information: Publishers Joseph J. D’Onofrio Frank M. Marino Delaware Media Group 66 South Maple Avenue Ridgewood, NJ 07450 Tel: 201-612-7676 Fax: 201-612-8282 Website: www.delmedgroup.com Editorial Director Nancy Monson Art Director James Ticchio Cover photo credit: ©SIS Illustration/Veer ©2008, Delaware Media Group, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this publication are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, APNA, NAPNAP, or McNeil Pediatrics, Division of OrthoMcNeil-Janssen Phar maceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC. Counseling Points™ Caring for Individuals with ADHD Throughout the Lifespan: An Introduction to ADHD Continuing Education Information Target Audience This educational activity is designed to educate psychiatric nurses about issues related to caring for individuals with attention deficit hyperactivity disorder (ADHD) throughout their lifespan. Learning Objectives Upon completion of this educational activity, the participant should be able to: • State the prevalence and economic burden of attention deficit hyperactivity disorder (ADHD) • Discuss the pathophysiology and risk factors for ADHD • Determine the signs and symptoms of ADHD and common co-morbidities that may confound diagnosis • Identify ADHD across the lifespan APNA Disclaimer The American Psychiatric Nurses Association (APNA) presents the information in Counseling PointsTM as a service to its members. While APNA makes every effort to present accurate and reliable information, Counseling PointsTM contains information created or otherwise provided by individuals or organizations independent of APNA. APNA is not responsible for and does not endorse, approve, or guarantee the accuracy of the information presented, and expressly disclaims all liability for damages of any kind arising out of use, reference to, or reliance on such information. NAPNAP Disclaimer The National Association of Pediatric Nurse Practitioners’ (NAPNAP) approval of this activity or continuing education credit does not imply product endorsement. Continuing Education Credit This program has been approved for 1.0 NAPNAP contact hours, of which 0 contain Pharmacology (Rx) content. Approved program #A10-08-E32. This program expires November 30, 2009. Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Psychiatric Nurses Association (APNA), NAPNAP, McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC, and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the APNA, NAPNAP, McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC, and Delaware Media Group. Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other healthcare professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities. COUNSELING POINTS™ 2 http://www.delmedgroup.com

Table of Contents Feed for the Digital Edition of Counseling Points - Psychiatric Nurse 11/08

Counseling Points - Psychiatric Nurse 11/08

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.